Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 5/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5424467 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TDP1TSHRCYP3A4LMNA | |
| SCHEMBL1697645 | 0.94 | LMNA (0.55) | ALDH1A1TDP1TSHRCYP3A4LMNA | |
| SCHEMBL506062 | 0.93 | ALDH1A1 (0.58) | ALDH1A1TDP1TSHRCYP3A4LMNA | |
| SCHEMBL1944724 | 0.91 | LMNA (0.59) | ALDH1A1TDP1TSHRCYP3A4LMNA | |
| SCHEMBL10582089 | 0.91 | LMNA (0.59) | ALDH1A1TDP1TSHRCYP3A4LMNA | |
| SCHEMBL2991307 | 0.91 | LMNA (0.59) | ALDH1A1TDP1TSHRCYP3A4LMNA | |
| SCHEMBL5488763 | 0.91 | LMNA (0.59) | ALDH1A1TDP1TSHRCYP3A4LMNA | |
| SCHEMBL11821234 | 0.91 | LMNA (0.59) | ALDH1A1TDP1TSHRCYP3A4LMNA | |
| SCHEMBL8679451 | 0.90 | LMNA (0.57) | ALDH1A1TDP1TSHRCYP3A4LMNA | |
| SCHEMBL4072853 | 0.90 | LMNA (0.57) | ALDH1A1TDP1TSHRCYP3A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026043730-A1 | METHODS FOR PRODUCING AVIATION FUELS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-26 | — | — | WO | claimed |
| CN-117941117-A | Electrolyte, secondary battery, battery module, battery pack, and electricity device | 宁德时代新能源科技股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-105694028-A | Interfacial polymeric oil-phase reaction composition for preparing composite reverse osmosis membranes and use method thereof | 贵阳时代沃顿科技有限公司 | 2016-06-22 | — | — | CN | claimed |
| CN-122070352-A | Sustainable aviation fuel produced from normal alpha olefin byproducts and method thereof | 切弗朗菲利浦化学公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-2026100731-A1 | COMPOSITION FOR OPTICAL MATERIAL, POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, OPTICAL MATERIAL, AND LENS | 三井化学株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-12618016-B2 | Methods for producing aviation fuels | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260103649-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2026-04-16 | — | — | US | disclosed |
| WO-2026043730-A1 | METHODS FOR PRODUCING AVIATION FUELS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-26 | — | — | WO | disclosed |
| US-20260049256-A1 | METHODS FOR PRODUCING AVIATION FUELS | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2026-02-19 | — | — | US | disclosed |
| US-12540287-B2 | Sustainable aviation fuel from normal alpha olefin byproducts and process for same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-03 | — | — | US | disclosed |
| EP-3919584-B1 | METHOD FOR PRODUCING POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL | MITSUI CHEMICALS INC (JP) | 2025-12-24 | — | — | EP | disclosed |
| EP-2084171-A1 | IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE | Showa Denko K.K. (JP) | 2009-08-05 | — | — | EP | disclosed |
| EP-2065414-A1 | POLYMERIZATION CATALYST FOR POLYTHIOURETHANE OPTICAL MATERIAL, POLYMERIZABLE COMPOSITION CONTAINING THE CATALYST, POLYTHIOURETHANE RESIN OBTAINED FROM THE COMPOSITION, AND METHOD FOR PRODUCING THE RESIN | Mitsui Chemicals, Inc. (JP) | 2009-06-03 | — | — | EP | disclosed |
| WO-2008056799-A1 | IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE | SHOWA DENKO K.K. (JP) | 2008-05-15 | — | — | WO | disclosed |
| EP-0735101-B1 | Method for the preparation of one-package room-temperature-curable silicone elastomer compositions | DOW CORNING TORAY SILICONE (JP) | 2003-06-04 | — | — | EP | disclosed |
| US-5859178-A | Polymerization of caprolactam with certain quaternary ammonium compounds | PURITEK, INC (US) | 1999-01-12 | — | — | US | disclosed |
| US-5780543-A | NONSLUMPING; NONCRACKING; NONYELLOWING; MIXING AN HYDROXYL-TERMINATED DIORGANOPOLYSILOXANE AND AN ALKYL-CONTAINING OXIMOSILANE | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 1998-07-14 | — | — | US | disclosed |
| EP-0735101-A2 | Method for the preparation of one-package room-temperature-curable silicone elastomer compositions | Dow Corning Toray Silicone Company Limited (JP) | 1996-10-02 | — | — | EP | disclosed |
| US-4904814-A | CATALYTIC TRANSESTERIFICATION OF METHYL OR ETHYL ESTERS WITH TERTIARY ALCOHOL | CIBA-GEIGY CORPORATION (US) | 1990-02-27 | — | — | US | disclosed |
| EP-0278914-A2 | Process for the preparation of tert.-alkyl esters of succinic acid | CIBA-GEIGY AG (CH) | 1988-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618016-B2 | Methods for producing aviation fuels | CYP4F8, CYP8B1, CYP2E1 | ALDH1A1 585/4885TDP1 871/4885TSHR 4270/4885 |
| US-20260103649-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | YAP1, CYP4F8, SCD | ALDH1A1 1235/4885TDP1 2398/4885TSHR 4325/4885 |
| US-20260049256-A1 | METHODS FOR PRODUCING AVIATION FUELS | CYP4F8, CPT1A, CBR1 | ALDH1A1 902/4885TDP1 930/4885TSHR 4431/4885 |
| US-12540287-B2 | Sustainable aviation fuel from normal alpha olefin byproducts and process for same | ADH1A, ADH1C, YAP1 | ALDH1A1 281/4885TDP1 2764/4885TSHR 3824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.